findmyKOL

Nancy Olsen, MD

Enriched profile

Professor of Medicine and Chief, Division of Rheumatology; H. Thomas and Dorothy Willits Hallowell Chair in Rheumatology · Penn State Milton S. Hershey Medical Center

ORCIDNPI
Region🇺🇸 Hershey, PA · Northeast · United StatesSpecialtyRheumatologyFocusLupus (SLE)
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2015–2022

Nancy Olsen is Professor of Medicine and Chief, Division of Rheumatology; H. Thomas and Dorothy Willits Hallowell Chair in Rheumatology at Penn State Milton S. Hershey Medical Center. OpenAlex indexes 347 publications with 17,545 citations (h-index 73); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Nancy Olsen, MD, is Professor of Medicine and Chief, Division of Rheumatology at Penn State Milton S. Hershey Medical Center / Penn State College of Medicine. The public record shows 347 publications with 17,545 citations (h-index 73), centered on Lupus (SLE). It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies, 3 NIH-funded awards (2015–2022).

  • Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
  • Top research focus: Lupus (SLE)
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lupus (SLE)2 trialsST Elevation Myocardial Infarction1 trialErythema1 trialGlomerular Disease1 trialNephritis1 trial

Research focus

OpenAlex concept fingerprint
Lupus (SLE)

Drugs & molecules

across trials, industry payments and publications
Actemrageneric · TocilizumabClinical trialsIndustry payments7Publications

Works with

trial sponsors and companies reporting payments
Genentech USA, Inc.Clinical trialsIndustry payments7UCB, Inc.Clinical trialsIndustry payments4Ge HealthcareClinical trialsIndustry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
347publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

17,545citations

Total citations across indexed works.

73h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2015–2022

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    31.2%
    Corticosteroid26.8%
    Prednisone100%
    Part D62 patients
    Aminosalicylate3.3%
    Sulfasalazine62%Sulfasalazine Dr39%
    Part D<11 patients
  • Nervous system

    21.5%
    Opioid Agonist8.9%
    Oxycodone Hcl56%Tramadol Hcl33%Oxycodone-Acetaminophen12%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug5.1%
    Meloxicam100%
    Part D11 patients
  • Cancer & immunology

    19.5%
    Folate Analog Metabolic Inhibitor5.8%
    Methotrexate100%
    Part D22 patients
    Antirheumatic Agent4.1%
    Leflunomide100%
    Part D<11 patients
5 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 20152022 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/nancy-olsen-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Other

    rheumnow.live/b/sp/nancy-olsen-1400

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumnow.live

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Rheumatology Fellowship

    University of Texas Southwestern Medical Center

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org
  • Internal Medicine Residency

    Medical College of Virginia / Virginia Commonwealth University

    1980
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org
  • MD

    University of Chicago Pritzker School of Medicine

    1977
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org
  • BS

    Biology, Brown University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psu.edu
  • MS

    Immunology, University of Chicago

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psu.edu
  • Board Certified

    Internal Medicine and Rheumatology, American Board of Internal Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Editorial & leadership roles

journal and society appointments
  • Chief

    Division of Rheumatology, Penn State Milton S. Hershey Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psu.edu
  • Principal Investigator / lead-site investigator

    SMILE Trial (Study of Antimalarials in Incomplete Lupus Erythematosus)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pennstatehealthnews.org

Awards & honors

honors on the public record
  • Clinician Scholar Award

    American College of Rheumatology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psu.edu

Secondary affiliations

appointments beyond the home institution
  • Assistant Professor of Medicine

    Vanderbilt University Medical Center

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org
  • Professor of Medicine (Rheumatology)

    University of Texas Southwestern Medical School, prior role; directed rheumatology fellowship program, held McGee Foundation Chair in Arthritis Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psu.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.